Universe Pharmaceuticals (UPC) Invested Capital: 2020-2024
- Universe Pharmaceuticals' Invested Capital rose 53.53% to $51.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $51.4 million, marking a year-over-year increase of 53.53%. This contributed to the annual value of $51.4 million for FY2024, which is 53.53% up from last year.
- According to the latest figures from Q3 2024, Universe Pharmaceuticals' Invested Capital is $51.4 million, which was up 47.61% from $34.8 million recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Invested Capital registered a high of $956.5 billion during Q3 2020, and its lowest value of $33.5 million during Q3 2023.
- In the last 3 years, Universe Pharmaceuticals' Invested Capital had a median value of $45.0 million in 2022 and averaged $45.3 million.
- Per our database at Business Quant, Universe Pharmaceuticals' Invested Capital crashed by 100.00% in 2021 and then surged by 53.53% in 2024.
- Over the past 5 years, Universe Pharmaceuticals' Invested Capital (Quarterly) stood at $956.5 billion in 2020, then plummeted by 100.00% to $47.0 million in 2021, then dropped by 17.66% to $38.7 million in 2022, then dropped by 13.58% to $33.5 million in 2023, then soared by 53.53% to $51.4 million in 2024.
- Its last three reported values are $51.4 million in Q3 2024, $34.8 million for Q1 2024, and $33.5 million during Q3 2023.
